BlackRock »

Immunovant shares owned by BlackRock

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $130M 4.9M 26.40
2024-03-31 $145M 4.5M 32.31
2023-09-30 $159M 4.1M 38.39
2023-06-30 $80M 4.2M 18.97
2023-03-31 $61M 3.9M 15.51
2022-12-31 $70M 3.9M 17.75
2022-06-30 $14M 3.6M 3.89
2021-06-30 $33M 3.1M 10.55
2021-03-31 $59M 3.7M 16.06
2020-12-31 $222M 4.8M 46.19
2020-09-30 $124M 3.5M 35.20
2020-03-31 $14M 903k 15.56
2019-12-31 $9.5M 600k 15.86